SCHEMBL51419

SCHEMBL51419

COCCOc1cc(OCCOC)c2cc(C(=O)c3ccccc3)c(=O)oc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
RAB9A P51151 3/20 0.53
NPC1 O15118 2/20 0.53
POLB P06746 2/20 0.53
KDM4E B2RXH2 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MAOB P27338 4/20 0.44
HDAC1 Q13547 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HPGD P15428 2/20 0.43
MIF P14174 1/20 0.43
MAOA P21397 1/20 0.43
PPARG P37231 2/20 0.42
PPARA Q07869 1/20 0.41
SLC16A3 O15427 1/20 0.40
ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29456868 1.00 ALDH1A1 (0.53) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL51591 0.90 ALDH1A1 (0.56) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL52048 0.89 ALDH1A1 (0.58) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL29253118 0.85 ALDH1A1 (0.62) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL52081 0.85 ALDH1A1 (0.68) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL11217204 0.82 MAOB (0.55) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL52178 0.82 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL29968097 0.82 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1POLBKDM4E
SCHEMBL6836386 0.81 SLC16A3 (0.58) ALDH1A1RAB9ASMN1; SMN2MAOBMEN1
SCHEMBL4567094 0.81 ALDH1A1 (0.51) ALDH1A1RAB9ANPC1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 381 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 US claimed
US-10919909-B2 Photoinitiated reactions LINTFIELD LIMITED (GB) 2021-02-16 US claimed
US-20190211031-A1 PHOTOINITIATED REACTIONS LINTFIELD LIMITED (GB) 2019-07-11 US claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 EP claimed
EP-4555025-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-05-13 EP disclosed
EP-3902878-B1 PHOTOINITIATORS IGM RESINS ITALIA SRL (IT) 2026-05-06 EP disclosed
EP-4534614-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-04-15 EP disclosed
EP-4722303-A1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM Group B.V. (NL) 2026-04-08 EP disclosed
EP-4273200-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-03-25 EP disclosed
US-20260071077-A1 POLYMERIC (METH)ACRYLATE PHOTOINITIATORS IGM RESINS ITALIA S.R.L. (IT) 2026-03-12 US disclosed
EP-4680655-A1 USE OF SPECIFIC PHOTOINITIATORS IN A PHOTOPOLYMERIZATION PROCESS USING COMBINED LED LIGHT WAVELENGTHS IGM Resins Italia S.r.l. (IT) 2026-01-21 EP disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
US-20010012596-A1 For resist applications; thermostability, storage stability CIBA SPECIALTY CHEMICALS CORP. 2001-08-09 US disclosed
WO-2001042313-A1 ADDITIVE COMPOSITION FOR INCREASING THE STORAGE STABILITY OF ETHYLENICALLY UNSATURATED RESINS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-06-14 WO disclosed
EP-1095313-A1 PHOTOPOLYMERIZABLE THERMOSETTING RESIN COMPOSITIONS Ciba SC Holding AG (CH) 2001-05-02 EP disclosed
WO-2000052530-A1 OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-09-08 WO disclosed
WO-2000000869-A1 PHOTOPOLYMERIZABLE THERMOSETTING RESIN COMPOSITIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-01-06 WO disclosed
US-5145885-A Morpholine compound, binders CIBA-GEIGY CORPORATION (US) 1992-09-08 US disclosed
US-4992547-A Aminoaryl ketone photoinitiators CIBA-GEIGY CORPORATION (US) 1991-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919909-B2 Photoinitiated reactions KMO, DECR1, PPOX ALDH1A1 262/4885RAB9A 3269/4885NPC1 2000/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 ALDH1A1 3984/4885RAB9A 2155/4885NPC1 872/4885
US-20260071077-A1 POLYMERIC (METH)ACRYLATE PHOTOINITIATORS CCNY, CHRM2, CHRM5 ALDH1A1 1918/4885RAB9A 4202/4885NPC1 4238/4885
US-20190211031-A1 PHOTOINITIATED REACTIONS DOHH, PAH, DBH ALDH1A1 179/4885RAB9A 4138/4885NPC1 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.